Study Stopped
Futility
Cerebral Microembolism in the Critically Ill With Acute Kidney Injury
COMET-AKI
Sponsor study identifier
interventional
66
1 country
1
Study Start
January 2017
Date type not reportedThis date has not been verified as actual or estimated.
Primary Completion
November 6, 2022
Actual (reported)Study Completion
November 6, 2022
Actual (reported)The primary objective of this study is to investigate the impact of continuous renal replacement therapy and intermittent renal replacement therapy on microbubble / cerebral microemboli generation in a cohort of critically ill patients with dialysis-dependent acute kidney injury.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
November 6, 2022
Actual (reported)Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
November 20, 2015
Actual (reported)December 3, 2015
Actual (reported)January 2017
Date type not reportedThis date has not been verified as actual or estimated.
November 6, 2022
Actual (reported)November 6, 2022
Actual (reported)Cerebral Microembolic Load detected by Transcranial Doppler Ultrasound
During hemodialysis therapy
the CRRT group receives continuous renal replacement therapy for acute kidney injury
the IRRT group receives intermittent renal replacement therapy after termination of CRRT.
Patients receive renal replacement therapy according to institutional standards
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
University Hospital Bern
Bern, 3010, Switzerland
Erdoes G, Uehlinger DE, Kobel B, Stucki MP, Wiest R, Stueber F, Fankhauser N, Jakob SM, Schefold JC. Cerebral microembolism in the critically ill with acute kidney injury (COMET-AKI trial): study protocol for a randomized controlled clinical trial. Trials. 2018 Mar 21;19(1):189. doi: 10.1186/s13063-018-2561-3.
Gabor Erdoes, MD
University of Berne
66 participants (actual enrollment reported by the registry).
First Submitted
November 20, 2015
First Posted
December 3, 2015
Study Start
January 2017
Date type not reportedThis date has not been verified as actual or estimated.
Evaluation of the Effectiveness of Extracorporeal Methods for Removing Mediators of Systemic Inflammation
Contact the study team to confirm eligibility.
Primary Completion
November 6, 2022
Actual (reported)Study Completion
November 6, 2022
Actual (reported)Last Updated
November 14, 2022
Record last verified: 2022-11
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: